European HQ Growth Shionogi Europe operates as the European headquarters of a global pharmaceutical company, with multiple European offices and over 300 staff. This presents a opportunity to engage in partnerships, distribution agreements, and regional commercialization collaborations across major EU markets.

AMR and Infectious Disease Focus The company emphasizes antimicrobial resistance, HIV, influenza, and infectious disease therapies. Sales teams can target collaborations for antimicrobial products, diagnostic tools, and companion therapeutics, as well as potential public health and hospital partnerships in Europe.

Hospital Specialty Expansion In addition to infectious disease, Shionogi Europe has expertise in Hospital Specialty areas affecting quality of life, especially Women’s Health. Opportunities exist in specialty product partnerships, clinical studies, and value-added services for hospitals and clinics.

Strategic Partnerships & M&A The organization highlights open collaboration and partnerships, with growth plans including partnerships and acquisitions to accelerate development. This signals receptiveness to BD&L deals, licensing, co-development, and regional distribution agreements.

Digital & Global Footprint With a tech stack spanning SAS Viya, Python and digital tools, plus a history of global collaborations and CVC activity, there are avenues for digital health solutions, data analytics partnerships, and platform integrations to support regulatory, pharmacovigilance, and market access initiatives.